Drug Discovery - Scaling Small Molecules for Commercial Drug Discovery
View as a Web Page
News Medical
 
  Drug Discovery Drug Discovery logo  
  The latest drug discovery news from News Medical  
 

Innovative Solutions for Viral Infectious Disease ResearchInnovative Solutions for Viral Infectious Disease Research

As a global supplier of viral reagents, Sino Biological offers a comprehensive range of viral research tools for infectious disease research. Sino Biological's viral reagents focuses on new outbreaks, latest strains, vaccine strains, and critical molecules, empowering researchers to address emerging health threats.

Access Viral Reagents
 
 
    Scaling Small Molecules for Commercial Drug DiscoveryScaling Small Molecules for Commercial Drug Discovery
 
Explore how CMC experts are transforming small molecule development from Phase II to commercial readiness. Featuring insights from Pharmaron and consultant James Bruno, this webinar reveals key scale-up considerations—from process safety and analytical technology to green metrics and manufacturing optimisation—shaping the next generation of drug discovery pipelines.
 
Explore Expert Insights on Small Molecule Scale-Up
 
 
   New light-activated method revolutionizes creation of drug building blocksNew light-activated method revolutionizes creation of drug building blocks
 
A team of organic and computational chemists at the University of Minnesota Twin Cities have created a new, modern tool to make the process of creating pharmaceuticals and agrochemicals faster, cost-effective, and energy-efficient.
 
   World’s first experimental lung cancer vaccine to enter clinical trialsWorld’s first experimental lung cancer vaccine to enter clinical trials
 
People at high risk of lung cancer will soon be able to receive the first ever experimental vaccine designed to prevent the disease, in a world-first clinical trial led by researchers at UCL and the University of Oxford.
 
   New medication offers potential treatment for patients with deadliest form of blood cancerNew medication offers potential treatment for patients with deadliest form of blood cancer
 
Biomedical research that began at the University of Virginia School of Medicine has yielded a much-needed new treatment for patients with the deadliest form of blood cancer.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025